SAB BIO Raises $175 Million in Oversubscribed Private Placement

Leila Ahmed North America Legal Chronicle
Tagged:

Dentons US LLP has advised SAB Biotherapeutics, Inc. on the transaction, and WilmerHale has advised RA Capital Management as lead investor.SAB BIO (Nasdaq: SABS), a clinical-stage…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here